Alcon is the world's largest eye care device company, founded in 1945 and now operating in more than 60 countries while serving patients across 140 countries globally. The company develops and manufactures surgical equipment, vision correction devices, pharmaceutical treatments, and diagnostic technologies for ophthalmology and broader eye care applications.
The company's product portfolio includes AcrySof intraocular lenses, which are used in vision correction procedures, and DAILIES TOTAL1 water gradient contact lenses, among other offerings. Alcon maintains a substantial commitment to innovation, investing $876 million annually in research and development with more than 70 products currently under development.
Alcon's operations span the full spectrum of eye care, from surgical instruments and devices to pharmaceuticals and diagnostics. The company positions itself on a heritage of establishing industry standards in ophthalmology and continues to develop solutions aimed at addressing vision correction and broader ocular health needs.